Tectonic Therapeutic to present positive phase 1a results of TX45, …
2 天之前 · Tectonic Therapeutic, Inc., a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs, announced detailed results from the phase 1a clinical trial of its lead asset, TX45, a long-acting, Fc-relaxin ...
India's most comprehensive portal on pharmaceutical News, …
2024年11月6日 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Paratek Pharma announces positive top-line data from phase 2b …
3 天之前 · Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for serious diseases, announced top-line results from its phase 2b study of oral omadacycline in adult patients with Nontuberculous ...
DoP releases operational guidelines for Strengthening of Medical …
3 天之前 · Gireesh Babu, New Delhi. Tuesday, November 12, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly announced central sector scheme for Strengthening of Medical Device Industry (SMDI), aiming at providing the much needed thrust to address the unmet needs of the medical devices ...
STEERLife & Callidus Research Laboratories forge strategic …
2 天之前 · STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global ...
About Us - Pharmabiz.com
Mr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi.He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China ...
EnteroBiotix reports positive results from phase 1b IMPuLCE study …
2 天之前 · EnteroBiotix’s first-in-human study of EBX-102 was a randomised, double-blind, placebo-controlled Ph1b study of adult participants with stable liver cirrhosis. It was designed to evaluate the safety, tolerability, and translational biomarker effects of two different doses of EBX-102. The study was conducted across ten sites in the United Kingdom.
PharmaBiz
The sections included in Pharmabiz Services are: You could also subscribe to ePharmail, the daily electronic newsletter from Pharmabiz or a special combined package offer for Pharmabiz Services + ePharmail is available at a discounted rate. For …
Neurizon Therapeutics receives positive opinion on orphan …
2 天之前 · Neurizon Therapeutics Limited (Neurizon), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, announced it has received notice of a positive opinion from the European Medicines Agency (EMA) for Orphan Medicinal Product Designation (OMPD) following its application ...
Novo Nordisk announces positive results from phase 3 ESSENCE …
2024年11月5日 · Novo Nordisk, a leading global healthcare company, announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis (stage 2 ...